Alkaloids found in Erythroxylum coca

Next Generation Labs Granted Australian Patent for the Use of TFN® Combinational R- and S-Isomer Synthetic Nicotine in Tobacco Cessation Products

Retrieved on: 
Thursday, July 22, 2021

"*

Key Points: 
  • "*
    From its inception, Next Generation Labs has "committed itself to the development of synthetic nicotine technology that can be used in modern nicotine delivery products.
  • The Company first started producing bulk synthetic nicotine in 2014, at a time when there was no commercial availability of isolated R- and S-isomer nicotine.
  • *S-isomer nicotine is the nicotine form that naturally occurs in tobacco and that is often processed into tobacco derived nicotine liquids, or used in pharmaceutical nicotine cessation products such as patches and gums.
  • NGL's TFN products are manufactured under strict conditions to meet cGMP, USP and EU standards to achieve a level of 99.97% pure synthetic nicotine.

EU Herbal Smoking Products with Nicotine Regulatory Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021

The "Regulatory Report: EU Regulation of Herbal Smoking Products with Nicotine" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: EU Regulation of Herbal Smoking Products with Nicotine" report has been added to ResearchAndMarkets.com's offering.
  • This report analyses EU member states' interpretation of herbal smoking products containing nicotine, which are not explicitly regulated at the EU level.
  • It also provides an overview of the regulations that apply to herbal products for smoking, regardless of whether they contain nicotine.
  • The products to be analysed in this report are herbal nicotine products or so-called non-tobacco cigarettes, which are composed of a mixture of various herbs plus nicotine.

Austria Modern Oral Tobacco Products Market report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021

The "Market Report: Modern Oral Products in Austria" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Market Report: Modern Oral Products in Austria" report has been added to ResearchAndMarkets.com's offering.
  • Nicotine pouches are widely available in Austria both online and offline.
  • This report is based on our survey and analysis of both the online and offline modern oral markets.
  • It includes information on availability of modern oral products, top brands, product characteristics such as most available flavour categories and most available nicotine strengths, and pricing information.

Next Generation Labs Granted European Patent for TFN® Synthetic Nicotine Manufacturing Process Further Strengthening IP Enforcement Efforts Against TFN® Violators

Retrieved on: 
Monday, June 28, 2021

3209653), for its proprietary technology related to the preparation of R-S isomer nicotine.

Key Points: 
  • 3209653), for its proprietary technology related to the preparation of R-S isomer nicotine.
  • "This patent grant by the European Patent Office is a significant milestone for Next Generation Labs, as it solidifies our tobacco-free synthetic nicotine intellectual property portfolio across a number of European countries, allowing the Company to better enforce its rights against violators and counterfeiters of its industry leading TFN branded synthetic nicotine.
  • About Next Generation Labs ('NGL'): Since 2014 NGL has been the world's largest manufacturer of S-isomer, combinational R/S isomer and R-isomer synthetic nicotine under the federally-registered brand name TFN.
  • NGL's TFN products are manufactured under strict conditions to meet cGMP, USP and EU standards to achieve a level of 99.97% pure synthetic nicotine.

22nd Century Group Provides Business Update from CEO Detailing Company Progress Over Past Year and Future Initiatives

Retrieved on: 
Friday, June 25, 2021

It has now been just over one year since I was appointed CEO of 22nd Century Group, and I would like to thank you for your enthusiasm and support of our Company.

Key Points: 
  • It has now been just over one year since I was appointed CEO of 22nd Century Group, and I would like to thank you for your enthusiasm and support of our Company.
  • Shares of 22nd Century have soared over 470% in the past 12 months.
  • The new technology provides 22nd Century with a rapid pathway to introduce reduced nicotine traits into virtually all varieties of tobacco.
  • 22nd Century has reached a true inflection point in our business -- and the best is yet to come.

Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction

Retrieved on: 
Thursday, June 10, 2021

Specifically, inhibitors of PDE7 reduced nicotine consumption and relapse in rodent models of nicotine abuse.

Key Points: 
  • Specifically, inhibitors of PDE7 reduced nicotine consumption and relapse in rodent models of nicotine abuse.
  • The research was conducted in collaboration with the School of Pharmacy of the University of Camerino in Italy.
  • Recent developments such as forms of electronic nicotine delivery are contributing to a new surge of nicotine use, especially in young adults.
  • Omeros owns global rights to the use of PDE7 inhibitors for the treatment of addictive disorders.

22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference

Retrieved on: 
Tuesday, May 18, 2021

The session will focus on the health disparities caused by tobacco and nicotine products among different groups within society, including a review of the use of mentholated products and their disproportionately high impact on African Americans.

Key Points: 
  • The session will focus on the health disparities caused by tobacco and nicotine products among different groups within society, including a review of the use of mentholated products and their disproportionately high impact on African Americans.
  • With our VLN\xc2\xae King and VLN\xc2\xae Menthol King reduced nicotine content (RNC) cigarettes, 22nd Century provides the only combustible tobacco products able to meet the nicotine level in the FDA\xe2\x80\x99s proposed mandate.
  • The feasibility of a low nicotine product standard is clear, the science is clear, and the benefits to our society are clear.
  • Public health can and must be advanced and we must ensure that no one in our society is left behind,\xe2\x80\x9d said John Pritchard.

Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century

Retrieved on: 
Thursday, April 1, 2021

By way of support, four former U.S. Food and Drug Administration (FDA) commissioners, Robert M. Califf, M.D.

Key Points: 
  • By way of support, four former U.S. Food and Drug Administration (FDA) commissioners, Robert M. Califf, M.D.
  • We believe that the Agency will advance their Comprehensive Plan and soon announce its simple, yet powerful reduced nicotine product standard.
  • Made from tobacco engineered by 22nd Century to contain 95% less nicotine than traditional cigarettes, VLN is the only combustible product that complies with the FDAs proposed nicotine cap.
  • The designation will allow 22nd Century to communicate key features of VLN King and VLN Menthol King, including a headline claim of 95% less nicotine.

Next Generation Labs LLC has been granted a Notice of Allowance from China for its Process for The Preparation of (R-S) Synthetic Nicotine - Patent #201580069647.2

Retrieved on: 
Monday, March 22, 2021

Since 2014, NGL has been the leading developer of tobacco-free synthetic nicotine for the vaping, oral nicotine and smoking markets.

Key Points: 
  • Since 2014, NGL has been the leading developer of tobacco-free synthetic nicotine for the vaping, oral nicotine and smoking markets.
  • In many instances, the nicotine contained in these products is not synthetic, tobacco-free or non-tobacco, but is in fact derived from tobacco sources.
  • About Next Generation Labs ('NGL'): Since 2014 NGL has been the world's largest manufacturer of S-isomer, R-S isomer and R-isomer synthetic nicotine under the federally-registered brand name TFN.
  • NGL's TFN products are manufactured under strict conditions to meet cGMP, USP and EU standards to achieve a level of 99.97% pure synthetic nicotine.

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Brings ‘Same Format, Different Ingredients’ Model to Smoking Market

Retrieved on: 
Thursday, February 25, 2021

Today, burgers and seafood look, smell and taste like hamburger and crabmeat, respectively, while being made from plants.

Key Points: 
  • Today, burgers and seafood look, smell and taste like hamburger and crabmeat, respectively, while being made from plants.
  • TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) has brought the same format, different ingredients model to the smoking market like no one before.
  • About TAATLifestyle & Wellness Ltd.
    TAAT Lifestyle and Wellness has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties.
  • By cutting through the overload of information in todays market, NNW brings its clients unparalleled visibility, recognition and brand awareness.